Anadigics (ANAD) Inactive 10-Q7 May 142014 Q1 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 29, 2014
Document and Entity Information [Abstract]	'
Entity Registrant Name	'ANADIGICS INC
Entity Central Index Key	'0000940332
Current Fiscal Year End Date	'--12-31
Entity Well-known Seasoned Issuer	'No
Entity Voluntary Filers	'No
Entity Current Reporting Status	'Yes
Entity Filer Category	'Accelerated Filer
Entity Common Stock, Shares Outstanding	85,561,053
Document Fiscal Year Focus	'2014
Document Fiscal Period Focus	'Q1
Document Type	'10-Q
Amendment Flag	'false
Document Period End Date	29-Mar-14

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Mar. 29, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 29, 2014	Dec. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$13,607	$20,947
Short-term marketable securities	450	3,447
Accounts receivable, net	12,421	15,156
Inventories	22,522	21,114
Prepaid expenses and other current assets	5,110	3,628
Total current assets	54,110	64,292
Plant and equipment	'	'
Equipment and furniture	204,741	203,797
Leasehold improvements	46,850	46,850
Projects in process	4,295	4,832
Plant and equipment, gross	255,886	255,479
Less accumulated depreciation and amortization	225,635	222,303
Plant and equipment, net	30,251	33,176
Other assets	213	213
Total assets	84,574	97,681
Current liabilities:	'	'
Accounts payable	10,837	13,043
Accrued liabilities	4,392	4,380
Accrued restructuring costs	529	245
Total current liabilities	15,758	17,668
Other long-term liabilities	1,501	1,604
Commitments and contingencies	'	'
Stockholders' equity	'	'
Common stock, $0.01 par value, 144,000 shares authorized, 85,676 issued at March 29, 2014 and 84,437 issued at December 31, 2013	857	844
Additional paid-in capital	639,762	637,922
Accumulated deficit	-573,495	-561,745
Accumulated other comprehensive income	450	1,647
Treasury stock at cost: 115 shares	-259	-259
Total stockholders' equity	67,315	78,409
Total liabilities and stockholders' equity	$84,574	$97,681

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)	Mar. 29, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Dec. 31, 2013
Stockholders' equity:	'	'
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, authorized (in shares)	144,000	144,000
Common stock, issued (in shares)	85,676	84,437
Treasury stock at cost (in shares)	115	115

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) [Abstract]	'	'
Net sales	$23,271	$26,380
Cost of sales	21,000	27,101
Gross profit (loss)	2,271	-721
Research and development expenses	8,576	10,280
Selling and administrative expenses	5,126	6,242
Restructuring charge	1,451	1,915
Operating loss	-12,882	-19,158
Interest income	5	93
Interest expense	-33	0
Other income, net	1,160	46
Net loss	($11,750)	($19,019)
Basic and diluted loss per share (in dollars per share)	($0.14)	($0.26)
Weighted average common shares outstanding used in computing loss per share	'	'
Basic and diluted (in shares)	84,763	73,158

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) [Abstract]	'	'
Net loss	($11,750)	($19,019)
Other comprehensive income	'	'
Unrealized (loss) gain on marketable securities	-37	1,118
Reclassification adjustment:	'	'
Net recognized gain on marketable securities previously included in Accumulated other comprehensive income	-1,160	-29
Comprehensive loss	($12,947)	($17,930)

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net loss	($11,750)	($19,019)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation	3,332	3,827
Amortization	17	21
Stock based compensation	1,843	1,501
Marketable securities recovery and accretion	-1,160	-29
Gain on disposal of equipment	0	-46
Changes in operating assets and liabilities:	'	'
Accounts receivable	2,735	-446
Inventories	-1,408	-1,473
Prepaid expenses and other assets	-1,499	-1,388
Accounts payable	-2,206	-2,776
Accrued liabilities and other liabilities	193	1,195
Net cash used in operating activities	-9,903	-18,633
CASH FLOWS FROM INVESTING ACTIVITIES	'	'
Purchases of plant and equipment	-407	-1,466
Purchases of marketable securities	0	-5,911
Proceeds from sale of marketable securities	2,960	17,724
Net cash provided by investing activities	2,553	10,347
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Issuance of common stock	10	18,419
Net cash provided by financing activities	10	18,419
Net (decrease) increase in cash and cash equivalents	-7,340	10,133
Cash and cash equivalents at beginning of period	20,947	24,949
Cash and cash equivalents at end of period	$13,607	$35,082

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 29, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	1	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	BASIS OF PRESENTATION

	The terms “we,” “our,” “ours,” “us” and “Company” refer to ANADIGICS Inc. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals and adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 29, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.

	The condensed consolidated balance sheet at December 31, 2013 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

	The Company has evaluated subsequent events and determined that, other than matters outlined in Note 10, there were no subsequent events to recognize or disclose in these unaudited interim condensed consolidated financial statements.

	IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS

	Changes to accounting principles generally accepted in the United States of America are established by the Financial Accounting Standards Board (FASB) in the form of Accounting Standards Updates to the FASB’s Accounting Standards Codification.

	In April 2014, the FASB issued amendments to guidance for reporting discontinued operations and disposals of components of an entity. The amended guidance requires that a disposal representing a strategic shift that has (or will have) a major effect on an entity’s financial results or a business activity classified as held for sale should be reported as discontinued operations. The amendments also expand the disclosure requirements for discontinued operations and add new disclosures for individually significant dispositions that do not qualify as discontinued operations. The amendments are effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December 15, 2014 (early adoption is permitted only for disposals that have not been previously reported). Adoption of the amended guidance is not expected to have a material impact on the Company’s condensed consolidated financial statements.

	INCOME TAXES

	The Company maintains a full valuation allowance on its deferred tax assets. Accordingly, the Company has not recorded a benefit or provision for income taxes. The Company recognizes interest and penalties related to the underpayment of income taxes in income tax expense. No unrecognized tax benefits, interest or penalties were accrued at March 29, 2014. The Company’s U.S. federal net operating losses have occurred since 1998 and as such, tax years subject to potential tax examination could apply from that date because carrying-back net operating loss opens the relevant year to audit.

	WARRANTY

	Based on the examination of historical returns and other information it deems critical, the Company estimates that a current charge to income will need to be provided in order to cover future warranty obligations for products sold during the year. The accrued liability for warranty costs is included in Accrued liabilities in the condensed consolidated balance sheets. Changes in the Company’s product warranty reserve are as follows:

			Three months ended
			29-Mar-14			30-Mar-13

	Beginning balance		$	383		$	770
	Additions charged to costs and expenses			51			108
	Claims processed			(101	)		(482	)
	Ending balance		$	333		$	396

	RECLASSIFICATIONS

	Certain prior period amounts have been reclassified to conform to the current presentation.

RESTRUCTURING

RESTRUCTURING	3 Months Ended
	Mar. 29, 2014
RESTRUCTURING [Abstract]	'
RESTRUCTURING	'
	2	RESTRUCTURING

	In February 2014, the Company implemented a workforce reduction that eliminated approximately 40 positions throughout the Company which resulted in the Company recording a restructuring charge of $1,451 during the first quarter of 2014 covering severance, related benefits and other costs. The unpaid balance at March 29, 2014 was $529 and was recorded within Accrued restructuring costs.

	In February 2013, the Company implemented a workforce reduction that eliminated approximately 25 positions throughout the Company which resulted in the Company recording a restructuring charge of $1,915 during the first quarter of 2013 for severance, related benefits and other costs.

	Activity and liability balances related to the restructurings were as follows:

			Accrued
			Restructuring
			Costs
	December 31, 2012 balance		$	395
	Restructuring expense			1,915
	Payments			(2,065	)
	December 31, 2013 balance		$	245
	Restructuring expense			1,451
	Payments			(1,167	)
	March 29, 2014 balance		$	529

FAIR_VALUE_AND_MARKETABLE_SECU

FAIR VALUE AND MARKETABLE SECURITIES	3 Months Ended
FAIR VALUE AND MARKETABLE SECURITIES	Mar. 29, 2014
FAIR VALUE AND MARKETABLE SECURITIES [Abstract]	'
FAIR VALUE AND MARKETABLE SECURITIES	'
	3	FAIR VALUE AND MARKETABLE SECURITIES

	FAIR VALUE OF FINANCIAL INSTRUMENTS

	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Inputs used to measure fair value are classified in the following hierarchy:

	Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities

	Level 2	Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability

	Level 3	Unobservable inputs for the asset or liability

	The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table presents a summary of fair value information for available-for-sale securities as at December 31, 2013 and March 29, 2014:

							Fair Value Measurements at Reporting Date
							Using
	Security Type		Amortized		Fair		Quoted Prices
			Cost Basis		Value		in Active		Significant
			-1				Markets for		Other		Significant
							Identical		Observable		Unobservable
							Assets		Inputs		Inputs
							(Level 1)		(Level 2)		(Level 3)
	Former-auction corporate debt security (2)		$	1,800	$	2,997	$	-	$	2,997	$	-
	Auction Rate Security - Preferred Equity			-		450		-		-		450
	Total at December 31, 2013		$	1,800	$	3,447	$	-	$	2,997	$	450

	Auction Rate Security - Preferred Equity			-		450		-		-		450
	Total at March 29, 2014		$	-	$	450	$	-	$	-	$	450

		-1	Difference between amortized cost basis and fair value represents gross unrealized gains.
		-2	Available for sale debt security with a contractual maturity in excess of 10 years.

	In January 2014, the Level 2 former-auction corporate debt security was sold for $2,960, resulting in a realized gain of $1,160 which was recorded in the first quarter of 2014 to Other income, net.

	As of March 29, 2014, our remaining preferred equity auction rate security was valued at $450 applying a market comparables method where the ARS is valued based on indications from the secondary market of what discounts buyers demand when purchasing similar ARS. There was no change in the fair value of this equity auction rate security from December 31, 2013 to March 29, 2014.

	The fair value of each of the following instruments approximates their carrying value because of the short maturity of these instruments: cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities.

	For the three month period ended March 30, 2013, the table below provides a reconciliation of the beginning and ending balances for each type of security valued using a Level 3 valuation.

	($ in 000’s)		Fair Value
			Measurements Using
			Significant
			Unobservable
			Inputs (Level 3)
			Three months ended
			30-Mar-13
			Preferred Equity
			Securities (a)
	Balance at January 1, 2013		$	1,568
	Total gains or losses realized/unrealized
	Included in earnings (loss)			-
	Included in other comprehensive income(loss)			477
	Purchases, redemptions, and settlements			-
	Transfers in and/or out of Level 3			-
	Balance at March 30, 2013		$	2,045

	Amount of total gains or losses for the period included in earnings(loss) attributable to the change in unrealized gains or losses relating to assets still held at the reporting date			-

	(a) Preferred securities issued by subsidiaries of two publicly-held debt default insurers. For one security, a non-binding offer by the issuer to repurchase the security used a 5% discount. For the second security, the discounted cash flow model discount rate and market comparables model discount were 34% and 81%, respectively.

INVENTORIES

INVENTORIES	3 Months Ended
INVENTORIES	Mar. 29, 2014
INVENTORIES [Abstract]	'
INVENTORIES	'
	4	INVENTORIES

	Inventories are stated at the lower of cost (first-in, first-out method) or market. Inventories consist of the following:

			29-Mar-14		31-Dec-13

	Raw materials		$	6,941	$	7,323
	Work in process			9,753		8,424
	Finished goods			5,828		5,367
	Total		$	22,522	$	21,114

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 29, 2014
STOCKHOLDERS' EQUITY [Abstract]	'
STOCKHOLDERS' EQUITY	'
	5	STOCKHOLDERS’ EQUITY

	In March 2013, the Company completed an underwritten public offering (the March 2013 Offering) of 10,000 shares of common stock at a price of $2.00 per share, generating net proceeds to the Company of $18,374. Subsequent to the March 2013 Offering, the underwriters exercised a portion of an overallotment option and purchased an additional 704 shares in April 2013, generating net proceeds to the Company of $1,301.

STOCK_BASED_COMPENSATION

STOCK BASED COMPENSATION	3 Months Ended
STOCK BASED COMPENSATION	Mar. 29, 2014
STOCK BASED COMPENSATION [Abstract]	'
STOCK BASED COMPENSATION	'
	6	STOCK BASED COMPENSATION

	Equity Compensation Plans

	The Company has two active equity compensation plans under which equity securities are authorized for issuance to employees and/or directors and two plans (the 1995 Plan and 1997 Plan, described below) which have been terminated:
	§	The 1995 Long-Term Incentive and Share Award Plan for Officers and Directors (terminated February 28, 2005) (1995 Plan);
	§	The 1997 Long Term Incentive and Share Award Plan (terminated February 28, 2005) (1997 Plan);
	§	The 2005 Long Term Incentive and Share Award Plan (2005 Plan, collectively with the 1995 Plan and the 1997 Plan, the Plans); and
	§	The Employee Stock Purchase Plan (ESP Plan).

	Employees and outside directors have been granted restricted stock shares or units (collectively, restricted stock) and options to purchase shares of common stock under stock option plans adopted in 1995, 1997 and 2005. An aggregate of 4,913, 5,100 and 24,850 shares of common stock were reserved for issuance under the 1995 Plan, the 1997 Plan and the 2005 Plan, respectively. The Plans provide for the granting of stock options, stock appreciation rights, restricted stock and other share based awards to eligible employees and directors, as defined in the Plans. Option grants have terms of ten years and become exercisable in varying amounts over periods of up to three years. To date, no stock appreciation rights have been granted under the Plans.

	In 1995, the Company adopted the ESP Plan under Section 423 of the Internal Revenue Code. All full-time employees of ANADIGICS, Inc. and part-time employees, as defined in the ESP Plan, are eligible to participate in the ESP Plan. An aggregate of 6,694 shares of common stock were reserved for offering under the ESP Plan. Offerings are made at the commencement of each calendar year and must be purchased by the end of that calendar year. Pursuant to the terms of the ESP Plan, shares purchased and the applicable per share price were 271 and $1.64, respectively for the year ended December 31, 2013.

	The table below summarizes stock based compensation by source and by financial statement line item for the three month periods:

			Three months ended
			29-Mar-14				30-Mar-13
	Amortization of restricted stock			1,734			$	1,230
	Amortization of ESP Plan			60				150
	Amortization of stock option awards			49				121
	Total stock based compensation			1,843			$	1,501

	By Financial Statement line item
	Cost of sales			276			$	179
	Research and development expenses			554				345
	Selling and administrative expenses			1,013				1,048
	Restructuring charge			-				(71	)

	No tax benefits have been recorded due to the Company’s full valuation allowance position.

	Restricted Stock and Stock Option Awards

	Under the Plans, the Company grants restricted stock shares and units to its employees. The value of restricted stock grants are fixed upon the date of grant and amortized over the related vesting period, primarily ranging up to three years. Restricted stock is subject to forfeiture if employment terminates prior to vesting. The Company estimates that approximately 2.5% of its restricted stock and stock option awards are forfeited annually (exclusive of performance-based restricted stock awards and performance-based option shares, as described below). The restricted stock shares carry voting and certain forfeitable dividend rights commencing upon grant, whereas restricted stock units do not. Neither restricted stock shares nor restricted stock units may be traded or transferred prior to vesting. Grant, vest and forfeit activity and related weighted average (WA) price per share for restricted stock and for stock options during the period from January 1, 2013 to March 29, 2014 is presented in tabular form below:

			Restricted Stock Units							Stock Options
				Units				WA		Issuable			WA
								price/		upon			exercise
								unit		exercise			price

	Outstanding at January 1, 2013			1,430			$	4.63			2,495		$	4.89
	Granted (1)			3,509				2.11			13			2.26
	Shares vested/options exercised			(1,539	)			3.34			(69	)		1.93
	Forfeited/expired (2,3)			(528	)			2.5			(480	)		3.99
	Balance at December 31, 2013			2,872			$	2.63			1,959		$	5.2
	Granted (1)			2,070				1.85			3			1.91
	Shares vested/options exercised			(1,234	)			3.36			(5	)		1.83
	Forfeited/expired			(62	)			2.21			(617	)		5.88
	Balance at March 29, 2014			3,646				1.95			1,340			4.89

		-1	Years 2013 and 2014 restricted stock units granted include 560 and 412.5 performance-based restricted stock units, respectively.
		-2	Year 2013 restricted stock units forfeited include 384 performance-based units; Year 2013 stock options forfeited include 42 performance-based option shares.
		-3	In the second quarter of 2013, 125 time-based and 83 (125 at maximum performance achievement) performance-based stock options were rescinded with the consent of and without payment to the CEO due to the fact that the original grants with respect to which these options were a part of exceeded the sub-limits of the applicable plan by the number of shares as to which the options were rescinded.

	In June 2011, the Company’s Chief Executive Officer was awarded a base grant of 250 performance-based stock options contingent upon the Company’s shareholder return performance against the performance of the Philadelphia Semiconductor Index component companies. Following the rescission discussed in footnote (3) in the table immediately above, the base grant was reduced by 83 performance-based stock options during the second quarter of 2013. The award and performance is evaluated during the one, two and three year periods following the award. The performance-based stock options have an exercise price of $3.24, expire 10 years after the grant date, and had an average fair value of $2.62 on the date of grant. The fair value estimate was calculated with the assistance of a valuation consultant using a Monte Carlo Simulation model. In the second quarters of 2012 and 2013, 83 and 42 shares, respectively, were canceled for non-achievement of performance goals at the end of the first and second measurement periods.

	On February 16, 2012, subject to stockholder approval of additional 2005 Long-Term Incentive and Share Award Plan shares at the Company’s 2013 Annual Stockholder Meeting (at which such approval was received), the Company awarded 661 time-based and 220 performance-based restricted stock units to its officers and employees. The time-based restricted stock units vested one-third on May 20, 2013 and one-third on February 18, 2014, and vest one-third on February 18, 2015. The performance-based restricted stock units vest based on absolute total stockholder return for one-year, two-year and three-year periods starting from the baseline date of December 31, 2011, compared to total stockholder return targets for each of the respective periods. As of December 31, 2013, the performance metrics for the first and second year periods were not met on the performance-based awards and 155 restricted stock units were forfeited.

	On December 4, 2012, subject to stockholder approval of additional 2005 Long-Term Incentive and Share Award Plan shares at the Company’s 2013 Annual Stockholder Meeting (at which such approval was received), the Company awarded 660 restricted stock units to its officers and other key employees (subsequently increased by 20 units awarded to an additional officer in July 2013). Fifty percent of these restricted stock units have time-based vesting conditions and 50% have performance-based vesting conditions. The restricted stock units vest one-third annually in May 2014, 2015, and 2016 (August 2014, 2015 and 2016 vest for the July 2013 grant). The performance-based awards were evaluated based on the Company’s adjusted cash flow from operations for the year ended December 31, 2013, with 34.8% of the performance metrics achieved, 111 performance-based restricted stock units vested, and the remaining 229 performance-based stock units were forfeited.

	On February 13, 2014, the Company awarded 825 restricted stock units to its officers and other key employees where fifty percent of these restricted stock units have time-based vesting conditions and 50% have performance-based vesting conditions contingent upon the Company’s relative levels of shareholder returns against the peer group companies, as defined in the Company’s annual proxy statement, as filed with the SEC on March 21, 2014. The restricted stock units will vest, if at all, one-third annually in March 2015, 2016, and 2017. The performance-based awards and performance will be evaluated annually in one-third increments measuring Company shareholder returns during the one, two and three year periods following the award. Company performance below the 25th-percentile in a measurement period would result in no vesting for that period. The performance-based restricted stock units have an average fair value of $1.84 on the date of grant. The fair value estimate was calculated with the assistance of a valuation consultant using a Monte Carlo Simulation model.

			As of March 29, 2014
Unrecognized stock based compensation cost
Option plans		$	58
Restricted stock		$	4,675
Weighted average remaining recognition period
Option plans		0.7 Years
Restricted stock		1.8 Years

Stock options outstanding at March 29, 2014 are summarized as follows:

Range of exercise prices			Outstanding				Weighted			Weighted			Exercisable		Weighted
			Options at				average			average			at March 29,		average
			29-Mar-14				remaining			exercise			2014		exercise
							contractual			price					price
							life

$1.23 - $1.93				474				4.5		$	1.92			466	$	1.93
$2.00 - $3.24				317				6.9		$	3.19			240	$	3.2
$3.30 - $8.79				147				2.7		$	5.49			147	$	5.49
$8.84 - $18.98				402				2.5		$	9.49			402	$	9.49

Valuation Method for ESP Plan and Stock Option Awards

The fair value of these equity awards was estimated at the date of grant using a Black-Scholes option pricing model. The weighted average assumptions and fair values for stock based compensation grants used for the three month periods ended March 29, 2014 and March 30, 2013 are summarized below.

		Three months ended
		29-Mar-14				30-Mar-13
Stock option awards:
Risk-free interest rate			1.7	%			0.8	%
Expected volatility			58	%			72	%
Average expected term (in years)			5				5
Expected dividend yield			0	%			0	%
Weighted average fair value of options granted		$	0.97			$	1.53

ESP Plan:
Risk-free interest rate			0.1	%			0.1	%
Expected volatility			45	%			66	%
Average expected term (in years)			1				1
Expected dividend yield			0	%			0	%
Weighted average fair value of purchase option		$	0.49			$	0.72

For equity awards with an expected term of one year or less, the assumption for expected volatility is solely based on the Company’s historical volatility, whereas for equity awards with expected terms of greater than one year, the assumption is based on a combination of implied and historical volatility.

LOSS_PER_SHARE

LOSS PER SHARE	3 Months Ended
LOSS PER SHARE	Mar. 29, 2014
LOSS PER SHARE [Abstract]	'
LOSS PER SHARE	'
	7	LOSS PER SHARE

	The reconciliation of shares used to calculate basic and diluted loss per share consists of the following:

			Three months ended
			29-Mar-14		30-Mar-13
	Weighted average common shares for basic loss per share			84,763		73,158

	Effect of dilutive securities:
	Stock options (*)			-		-
	Unvested restricted shares (*)			-		-

	Adjusted weighted average shares for diluted loss per share			84,763		73,158

	*	Incremental shares from restricted shares and stock options are computed using the treasury stock method.

	For the three months ended March 29, 2014 and March 30, 2013, potential additional dilution arising from any of the Company's outstanding stock options or unvested restricted stock (shares or units) is detailed below. Such potential dilution was excluded as their effect was anti-dilutive.

			Three months ended
			29-Mar-14		30-Mar-13

	Stock options			1,340		2,437
	Unvested restricted shares and units			3,646		1,627

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE INCOME	3 Months Ended
ACCUMULATED OTHER COMPREHENSIVE INCOME	Mar. 29, 2014
ACCUMULATED OTHER COMPREHENSIVE INCOME [Abstract]	'
ACCUMULATED OTHER COMPREHENSIVE INCOME	'
	8	ACCUMULATED OTHER COMPREHENSIVE INCOME

	The changes in accumulated other comprehensive income are as follows (in thousands):

			Net Unrealized			Foreign			Total
			Gain (Loss) on			Currency
			Marketable			Translation
			Securities
	Balance at January 1, 2013		$	3,255		$	(3	)	$	3,252
	Other comprehensive income before reclassifications			1,118			-			1,118
	Amounts reclassified from accumulated other comprehensive income *			(29	)		-			(29	)
	Net current period other comprehensive income			1,089			-			1,089
	Balance at March 30, 2013		$	4,344		$	(3	)	$	4,341

	Balance at January 1, 2014		$	1,647		$	-		$	1,647
	Other comprehensive income before reclassifications			(37	)		-			(37	)
	Amounts reclassified from accumulated other comprehensive income *			(1,160	)		-			(1,160	)
	Net current period other comprehensive income			(1,197	)		-			(1,197	)
	Balance at March 29, 2014		$	450		$	-		$	450

	* Amounts reclassified are recorded within Other income, net in the Condensed Consolidated Statements of Operations.

LEGAL_PROCEEDINGS

LEGAL PROCEEDINGS	3 Months Ended
	Mar. 29, 2014
LEGAL PROCEEDINGS [Abstract]	'
LEGAL PROCEEDINGS	'
	9	LEGAL PROCEEDINGS

	The Company is a party to ordinary course litigation arising out of the operation of our business. The Company believes that the ultimate resolution of such ordinary course litigation should not have a material adverse effect on its consolidated financial condition or results of operations.

LINE_OF_CREDIT

LINE OF CREDIT	3 Months Ended
	Mar. 29, 2014
LINE OF CREDIT [Abstract]	'
LINE OF CREDIT	'
	10	LINE OF CREDIT

	In April 2013, the Company entered into a Revolving Credit and Security Agreement (the “Credit Agreement”) with PNC Bank, N.A., which Agreement was amended in December 2013 and further amended on April 30, 2014, to revise the minimum EBITDA covenants. The Credit Agreement provides the Company with a three-year revolving credit facility of $11,000 that expires on April 30, 2016. The facility is secured by certain cash balances with borrowing availability based upon Accounts receivable and compliance with covenants, including minimum EBITDA (as defined in the Credit Agreement) and certain capital expenditure limits. The Company may elect to borrow at rates approximating LIBOR plus 3.25%. The Credit Agreement contains a fee for any unused portion of the facility. As of March 29, 2014, the Company was in compliance with its covenants and there were no amounts outstanding under the Credit Agreement. On April 30, 2014, the Company entered into an Amended and Restated Collateral Assignment of Account as collateral security for the Company’s existing and future obligations to Lenders under the Credit Agreement.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 29, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
BASIS OF PRESENTATION	'
	BASIS OF PRESENTATION

	The terms “we,” “our,” “ours,” “us” and “Company” refer to ANADIGICS Inc. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals and adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 29, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.

	The condensed consolidated balance sheet at December 31, 2013 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

	The Company has evaluated subsequent events and determined that, other than matters outlined in Note 10, there were no subsequent events to recognize or disclose in these unaudited interim condensed consolidated financial statements.
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS	'
	IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS

	Changes to accounting principles generally accepted in the United States of America are established by the Financial Accounting Standards Board (FASB) in the form of Accounting Standards Updates to the FASB’s Accounting Standards Codification.

	In April 2014, the FASB issued amendments to guidance for reporting discontinued operations and disposals of components of an entity. The amended guidance requires that a disposal representing a strategic shift that has (or will have) a major effect on an entity’s financial results or a business activity classified as held for sale should be reported as discontinued operations. The amendments also expand the disclosure requirements for discontinued operations and add new disclosures for individually significant dispositions that do not qualify as discontinued operations. The amendments are effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December 15, 2014 (early adoption is permitted only for disposals that have not been previously reported). Adoption of the amended guidance is not expected to have a material impact on the Company’s condensed consolidated financial statements.
INCOME TAXES	'
	INCOME TAXES

	The Company maintains a full valuation allowance on its deferred tax assets. Accordingly, the Company has not recorded a benefit or provision for income taxes. The Company recognizes interest and penalties related to the underpayment of income taxes in income tax expense. No unrecognized tax benefits, interest or penalties were accrued at March 29, 2014. The Company’s U.S. federal net operating losses have occurred since 1998 and as such, tax years subject to potential tax examination could apply from that date because carrying-back net operating loss opens the relevant year to audit.
WARRANTY	'
	WARRANTY

	Based on the examination of historical returns and other information it deems critical, the Company estimates that a current charge to income will need to be provided in order to cover future warranty obligations for products sold during the year. The accrued liability for warranty costs is included in Accrued liabilities in the condensed consolidated balance sheets. Changes in the Company’s product warranty reserve are as follows:

		Three months ended
		29-Mar-14			30-Mar-13

	Beginning balance	$	383		$	770
	Additions charged to costs and expenses		51			108
	Claims processed		(101	)		(482	)
	Ending balance	$	333		$	396
RECLASSIFICATIONS	'
	RECLASSIFICATIONS

	Certain prior period amounts have been reclassified to conform to the current presentation.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Mar. 29, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Product warranty reserve	'
	Changes in the Company’s product warranty reserve are as follows:

		Three months ended
		29-Mar-14			30-Mar-13

	Beginning balance	$	383		$	770
	Additions charged to costs and expenses		51			108
	Claims processed		(101	)		(482	)
	Ending balance	$	333		$	396

RESTRUCTURING_Tables

RESTRUCTURING (Tables)	3 Months Ended
RESTRUCTURING (Tables)	Mar. 29, 2014
RESTRUCTURING [Abstract]	'
Activity and liability balances related to the restructurings	'
	Activity and liability balances related to the restructurings were as follows:

		Accrued
		Restructuring
		Costs
	December 31, 2012 balance	$	395
	Restructuring expense		1,915
	Payments		(2,065	)
	December 31, 2013 balance	$	245
	Restructuring expense		1,451
	Payments		(1,167	)
	March 29, 2014 balance	$	529

FAIR_VALUE_AND_MARKETABLE_SECU1

FAIR VALUE AND MARKETABLE SECURITIES (Tables)	3 Months Ended
FAIR VALUE AND MARKETABLE SECURITIES (Tables)	Mar. 29, 2014
FAIR VALUE AND MARKETABLE SECURITIES [Abstract]	'
Fair value of available-for-sale securities	'
	The following table presents a summary of fair value information for available-for-sale securities as at December 31, 2013 and March 29, 2014:

							Fair Value Measurements at Reporting Date
							Using
	Security Type		Amortized		Fair		Quoted Prices
			Cost Basis		Value		in Active		Significant
			-1				Markets for		Other		Significant
							Identical		Observable		Unobservable
							Assets		Inputs		Inputs
							(Level 1)		(Level 2)		(Level 3)
	Former-auction corporate debt security (2)		$	1,800	$	2,997	$	-	$	2,997	$	-
	Auction Rate Security - Preferred Equity			-		450		-		-		450
	Total at December 31, 2013		$	1,800	$	3,447	$	-	$	2,997	$	450

	Auction Rate Security - Preferred Equity			-		450		-		-		450
	Total at March 29, 2014		$	-	$	450	$	-	$	-	$	450

		-1	Difference between amortized cost basis and fair value represents gross unrealized gains.
		-2	Available for sale debt security with a contractual maturity in excess of 10 years.
Reconciliation of the beginning and ending balances for each type of security valued using a Level 3 valuation	'
	For the three month period ended March 30, 2013, the table below provides a reconciliation of the beginning and ending balances for each type of security valued using a Level 3 valuation.

	($ in 000’s)		Fair Value
			Measurements Using
			Significant
			Unobservable
			Inputs (Level 3)
			Three months ended
			30-Mar-13
			Preferred Equity
			Securities (a)
	Balance at January 1, 2013		$	1,568
	Total gains or losses realized/unrealized
	Included in earnings (loss)			-
	Included in other comprehensive income(loss)			477
	Purchases, redemptions, and settlements			-
	Transfers in and/or out of Level 3			-
	Balance at March 30, 2013		$	2,045

	Amount of total gains or losses for the period included in earnings(loss) attributable to the change in unrealized gains or losses relating to assets still held at the reporting date			-

	(a) Preferred securities issued by subsidiaries of two publicly-held debt default insurers. For one security, a non-binding offer by the issuer to repurchase the security used a 5% discount. For the second security, the discounted cash flow model discount rate and market comparables model discount were 34% and 81%, respectively.

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended
INVENTORIES (Tables)	Mar. 29, 2014
INVENTORIES [Abstract]	'
Inventories	'
	Inventories are stated at the lower of cost (first-in, first-out method) or market. Inventories consist of the following:

		29-Mar-14		31-Dec-13

	Raw materials	$	6,941	$	7,323
	Work in process		9,753		8,424
	Finished goods		5,828		5,367
	Total	$	22,522	$	21,114

STOCK_BASED_COMPENSATION_Table

STOCK BASED COMPENSATION (Tables)	3 Months Ended
STOCK BASED COMPENSATION (Tables)	Mar. 29, 2014
STOCK BASED COMPENSATION [Abstract]	'
Summary of stock-based compensation by source	'
	The table below summarizes stock based compensation by source and by financial statement line item for the three month periods:

			Three months ended
			29-Mar-14			30-Mar-13
	Amortization of restricted stock			1,734		$	1,230
	Amortization of ESP Plan			60			150
	Amortization of stock option awards			49			121
	Total stock based compensation			1,843		$	1,501

	By Financial Statement line item
	Cost of sales			276		$	179
	Research and development expenses			554			345
	Selling and administrative expenses			1,013			1,048
	Restructuring charge			-			(71	)
Restricted stock and stock option awards activity	'
	Grant, vest and forfeit activity and related weighted average (WA) price per share for restricted stock and for stock options during the period from January 1, 2013 to March 29, 2014 is presented in tabular form below:

			Restricted Stock Units						Stock Options
				Units			WA		Issuable			WA
							price/		upon			exercise
							unit		exercise			price

	Outstanding at January 1, 2013			1,430		$	4.63			2,495		$	4.89
	Granted (1)			3,509			2.11			13			2.26
	Shares vested/options exercised			(1,539	)		3.34			(69	)		1.93
	Forfeited/expired (2,3)			(528	)		2.5			(480	)		3.99
	Balance at December 31, 2013			2,872		$	2.63			1,959		$	5.2
	Granted (1)			2,070			1.85			3			1.91
	Shares vested/options exercised			(1,234	)		3.36			(5	)		1.83
	Forfeited/expired			(62	)		2.21			(617	)		5.88
	Balance at March 29, 2014			3,646		$	1.95			1,340		$	4.89

		-1	Years 2013 and 2014 restricted stock units granted include 560 and 412.5 performance-based restricted stock units, respectively.
		-2	Year 2013 restricted stock units forfeited include 384 performance-based units; Year 2013 stock options forfeited include 42 performance-based option shares.
		-3	In the second quarter of 2013, 125 time-based and 83 (125 at maximum performance achievement) performance-based stock options were rescinded with the consent of and without payment to the CEO due to the fact that the original grants with respect to which these options were a part of exceeded the sub-limits of the applicable plan by the number of shares as to which the options were rescinded.
Unrecognized stock based compensation cost	'
	The fair value estimate was calculated with the assistance of a valuation consultant using a Monte Carlo Simulation model.

			As of March 29, 2014
	Unrecognized stock based compensation cost
	Option plans		$	58
	Restricted stock		$	4,675
	Weighted average remaining recognition period
	Option plans		0.7 Years
	Restricted stock		1.8 Years
Stock options outstanding by exercise price range	'
	Stock options outstanding at March 29, 2014 are summarized as follows:

	Range of exercise prices			Outstanding			Weighted			Weighted			Exercisable		Weighted
				Options at			average			average			at March 29,		average
				29-Mar-14			remaining			exercise			2014		exercise
							contractual			price					price
							life

	$1.23 - $1.93				474			4.5		$	1.92			466	$	1.93
	$2.00 - $3.24				317			6.9		$	3.19			240	$	3.2
	$3.30 - $8.79				147			2.7		$	5.49			147	$	5.49
	$8.84 - $18.98				402			2.5		$	9.49			402	$	9.49
Weighted average assumptions and fair values for stock-based compensation grants	'
	The weighted average assumptions and fair values for stock based compensation grants used for the three month periods ended March 29, 2014 and March 30, 2013 are summarized below.

			Three months ended
			29-Mar-14			30-Mar-13
	Stock option awards:
	Risk-free interest rate			1.7	%		0.8	%
	Expected volatility			58	%		72	%
	Average expected term (in years)			5			5
	Expected dividend yield			0	%		0	%
	Weighted average fair value of options granted		$	0.97		$	1.53

	ESP Plan:
	Risk-free interest rate			0.1	%		0.1	%
	Expected volatility			45	%		66	%
	Average expected term (in years)			1			1
	Expected dividend yield			0	%		0	%
	Weighted average fair value of purchase option		$	0.49		$	0.72

LOSS_PER_SHARE_Tables

LOSS PER SHARE (Tables)	3 Months Ended
LOSS PER SHARE (Tables)	Mar. 29, 2014
LOSS PER SHARE [Abstract]	'
Reconciliation of shares used to calculate basic and diluted loss per share	'
	The reconciliation of shares used to calculate basic and diluted loss per share consists of the following:

			Three months ended
			29-Mar-14		30-Mar-13
	Weighted average common shares for basic loss per share			84,763		73,158

	Effect of dilutive securities:
	Stock options (*)			-		-
	Unvested restricted shares (*)			-		-

	Adjusted weighted average shares for diluted loss per share			84,763		73,158

	*	Incremental shares from restricted shares and stock options are computed using the treasury stock method.
Anti-dilutive shares excluded from the calculation of basic earnings per share	'
	For the three months ended March 29, 2014 and March 30, 2013, potential additional dilution arising from any of the Company's outstanding stock options or unvested restricted stock (shares or units) is detailed below. Such potential dilution was excluded as their effect was anti-dilutive.

			Three months ended
			29-Mar-14		30-Mar-13

	Stock options			1,340		2,437
	Unvested restricted shares and units			3,646		1,627

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	3 Months Ended
ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	Mar. 29, 2014
ACCUMULATED OTHER COMPREHENSIVE INCOME [Abstract]	'
Accumulated other comprehensive income	'
	The changes in accumulated other comprehensive income are as follows (in thousands):

		Net Unrealized			Foreign			Total
		Gain (Loss) on			Currency
		Marketable			Translation
		Securities
	Balance at January 1, 2013	$	3,255		$	(3	)	$	3,252
	Other comprehensive income before reclassifications		1,118			-			1,118
	Amounts reclassified from accumulated other comprehensive income *		(29	)		-			(29	)
	Net current period other comprehensive income		1,089			-			1,089
	Balance at March 30, 2013	$	4,344		$	(3	)	$	4,341

	Balance at January 1, 2014	$	1,647		$	-		$	1,647
	Other comprehensive income before reclassifications		(37	)		-			(37	)
	Amounts reclassified from accumulated other comprehensive income *		(1,160	)		-			(1,160	)
	Net current period other comprehensive income		(1,197	)		-			(1,197	)
	Balance at March 29, 2014	$	450		$	-		$	450

	* Amounts reclassified are recorded within Other income, net in the Condensed Consolidated Statements of Operations.

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'	'
Unrecognized tax benefits, interest or penalties accrued	$0	'
Changes in product warranty reserve [Roll Forward]	'	'
Beginning balance	383	770
Additions charged to costs and expenses	51	108
Claims processed	-101	-482
Ending balance	$333	$396

RESTRUCTURING_Details

RESTRUCTURING (Details) (USD $)	1 Months Ended		3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2014	Feb. 28, 2013	Mar. 29, 2014	Mar. 30, 2013	Dec. 31, 2013
	Position	Position	Mar. 29, 2014	Mar. 30, 2013	Dec. 31, 2013
RESTRUCTURING [Abstract]	'	'	'	'	'
Number of positions eliminated	40	25	'	'	'
Activity and liability balances related to the restructuring [Roll Forward]	'	'	'	'	'
Beginning Balance	'	'	$245	$395	$395
Restructuring expense	'	'	1,451	1,915	1,915
Payments	'	'	-1,167	'	-2,065
Ending Balance	'	'	$529	'	$245

FAIR_VALUE_AND_MARKETABLE_SECU2

FAIR VALUE AND MARKETABLE SECURITIES (Details) (USD $)

3 Months Ended

In Thousands, unless otherwise specified

Mar. 29, 2014

Dec. 31, 2013

Mar. 29, 2014

Dec. 31, 2013

Mar. 29, 2014

Dec. 31, 2013

Mar. 29, 2014

Dec. 31, 2013

Mar. 29, 2014

Dec. 31, 2013

Minimum [Member]

Amortized Cost Basis [Member]

Fair Value [Member]

Recurring [Member]

Quoted Prices in Active Markets for Identical Assets, Level 1 [Member]

Significant Other Observable Inputs, Level 2 [Member]

Significant Unobservable Inputs, Level 3 [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Former-auction corporate debt security

$1,800

[1],[2]

$2,997

[2]

$2,997

[2]

Auction Rate Security - Preferred Equity

[1]

450

Total

[1]

$1,800

[1]

$450

$3,447

$2,997

$450

Available for sale debt securities, contractual maturities

'10 years

[1]

Difference between amortized cost basis and fair value represents gross unrealized gains.

[2]

Available for sale debt securities with contractual maturities in excess of 10 years.

FAIR_VALUE_AND_MARKETABLE_SECU3

FAIR VALUE AND MARKETABLE SECURITIES, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) (USD $)	3 Months Ended						3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013		Dec. 31, 2013		Mar. 30, 2013	Mar. 30, 2013	Mar. 30, 2013
	Insurer	Corporate Debt Security [Member]	Preferred Equity Securities [Member]		Preferred Equity Securities [Member]		Preferred Security One [Member]	Preferred Security Second [Member]	Preferred Security Second [Member]
							DCF Discount Rate [Member]	DCF Discount Rate [Member]	Secondary Market Discount [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'		'		'	'	'
Balance, beginning of period	'	'	'		$1,568	[1]	'	'	'
Total gains or losses realized/unrealized [Abstract]	'	'	'		'		'	'	'
Included in earnings (loss)	'	'	0	[1]	'		'	'	'
Included in other comprehensive income (loss)	'	'	477	[1]	'		'	'	'
Purchases, redemptions, and settlements: [Abstract]	'	'	'		'		'	'	'
Purchases, redemptions, and settlements	'	'	0	[1]	'		'	'	'
Transfers in and/or out of Level 3	'	'	0	[1]	'		'	'	'
Balance, end of period	'	'	2,045	[1]	1,568	[1]	'	'	'
Number of publicly held debt of default insurers	2	'	'		'		'	'	'
Interest rate (in hundredths)	'	'	'		'		5.00%	34.00%	81.00%
Securities sold at par	'	2,960	'		'		'	'	'
Gain on sale	'	$1,160	'		'		'	'	'

[1]	Preferred securities issued by subsidiaries of two publicly-held debt default insurers. For one security, a non-binding offer by the issuer to repurchase the security used a 5% discount. For the second security, the discounted cash flow model discount rate and market comparables model discount were 34% and 81%, respectively.

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Mar. 29, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 29, 2014	Dec. 31, 2013
Inventories [Abstract]	'	'
Raw materials	$6,941	$7,323
Work in process	9,753	8,424
Finished goods	5,828	5,367
Total	$22,522	$21,114

STOCKHOLDERS_EQUITY_Details

STOCKHOLDERS' EQUITY (Details) (USD $)	1 Months Ended	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Apr. 30, 2013	Mar. 29, 2014
STOCKHOLDERS' EQUITY [Abstract]	'	'
Shares issued under public offering (in shares)	704	10,000
Share price (in dollars per share)	'	$2
Net proceeds from shares purchased by underwriters	$1,301	$18,374

STOCK_BASED_COMPENSATION_Detai

STOCK BASED COMPENSATION (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

In Thousands, except Share data, unless otherwise specified

Mar. 29, 2014

Mar. 30, 2013

Dec. 31, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Jun. 29, 2013

Dec. 31, 2013

Dec. 31, 2012

Jun. 29, 2013

Mar. 29, 2014

Jul. 31, 2013

Mar. 29, 2014

Dec. 31, 2012

Mar. 29, 2014

Mar. 31, 2012

Mar. 29, 2014

Mar. 30, 2013

Plan

$1.23 - $1.93 [Member]

$2.04 - $3.24 [Member]

$3.30 - $7.27 [Member]

$8.79 - $18.98 [Member]

Cost of Sales [Member]

Research and Development Expenses [Member]

Selling and Administrative Expenses [Member]

Restructuring Charge [Member]

Stock Options [Member]

Restricted Stock [Member]

Restricted Stock Units (RSUs) [Member]

Performance Award Shares [Member]

Time based Restricted Stock Units [Member]

Long Term Incentive and Share Award Plan 1995 [Member]

Long Term Incentive and Share Award Plan 1997 [Member]

Long Term Incentive and Share Award Plan 2005 [Member]

Employee Stock Purchase Plan [Member]

Maximum [Member]

Restricted Stock Units (RSUs) [Member]

Performance Award Shares [Member]

Time based Restricted Stock Units [Member]

STOCK BASED COMPENSATION [Abstract]

Number of equity compensation plans

Number of equity compensation plans terminated

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock reserved for issuance (in shares)

4,913,000

5,100,000

24,850,000

6,694,000

Terms of award

'10 years

Awards vesting period

'3 years

Shares purchased under ESP plan (in shares)

271,000

Purchase price of shares Under ESP Plan (in dollars per share)

$1.64

Share-based Compensation [Abstract]

Stock based compensation

$1,843

$1,501

$276

$179

$554

$345

$1,013

$1,048

($71)

$49

$121

$1,734

$1,230

$60

$150

Estimated annual forfeiture rate (in hundredths)

2.50%

Restricted Stock Shares and Restricted Stock Units, Number of Shares [Roll Forward]

Shares outstanding, Beginning balance (in shares)

2,872,000

1,430,000

Granted (in shares)

2,070,000

[1]

3,509,000

[1]

825,000

412,500

560,000

20,000

250,000

660,000

220,000

661,000

Shares vested/options exercised (in shares)

-1,234,000

-1,539,000

Forfeited/expired-rescinded (in shares)

-62,000

-528,000

[2],[3]

384,000

125,000

155,000

Shares outstanding, Ending balance (in shares)

3,646,000

2,872,000

Restricted Stock Shares and Restricted Stock Units, Weighted Average Price [Roll Forward]

Weighted average grant date fair value, Beginning balance (in dollars per share)

$2.63

$4.63

Granted (in dollars per share)

$1.85

[1]

$2.11

[1]

$0.49

$0.72

Shares vested/options exercised (in dollars per share)

$3.36

$3.34

Forfeited/expired-rescinded (in dollars per share)

$2.21

$2.50

[2],[3]

Weighted average grant date fair value, Ending balance (in dollars per share)

$1.95

$2.63

Options outstanding [Roll Forward]

Shares outstanding, Beginning balance (in shares)

1,959,000

2,495,000

Granted (in shares)

3,000

[1]

13,000

[1]

Shares vested/options exercised (in shares)

-5,000

-69,000

111,000

Forfeited/expired-rescinded (in shares)

-617,000

-480,000

[2],[3]

83,000

42,000

83,000

125,000

229,000

Shares outstanding, Ending balance (in shares)

1,340,000

1,959,000

Options, Weighted Average Exercise Price [Roll Forward]

Weighted average exercise price per share, Beginning balance (in dollars per share)

$5.20

$4.89

Weighted average exercise price, Granted (in dollars per share)

$1.91

[1]

$2.26

[1]

Weighted average exercise price, Shares vested/options exercised (in dollars per share)

$1.83

$1.93

Weighted average exercise price, Forfeited/expired-rescinded (in dollars per share)

$5.88

$3.99

[2],[3]

Weighted average exercise price per share, Ending balance (in dollars per share)

$4.89

$5.20

Average exercise prices (in dollars per share)

$3.24

Award vesting rights

'The time-based restricted stock units vested 1/3rd on May 20, 2013, and vest 1/3rd on February 18, 2014 and 1/3rd on February 18, 2015. The performance-based restricted stock units vest based on absolute total stockholder return for one-year, two-year and three-year periods starting from the baseline date of December 31, 2011, compared to total stockholder return targets for each of the respective periods.

'The award and performance is evaluated during the one, two and three year periods following the award.

Minimum percentage of company performance for restricted stock to vest (in hundredths)

25.00%

Average fair value (in dollars per share)

$0.97

$1.53

$1.84

$2.62

Percentage of performance metrics achieved

34.80%

Percentage of restricted stock units will have time based vesting conditions (in hundredths)

50.00%

Percentage of restricted stock units will have performance based vesting conditions (in hundredths)

50.00%

Unrecognized stock-based compensation cost [Abstract]

Option plans and restricted stock

$58

$4,675

Weighted average remaining contractual term for outstanding options and restricted stock

'0 years 8 months 12 days

'1 year 9 months 18 days

Weighted average assumptions and fair values for stock-based compensation grants [Abstract]

Risk-free interest rate (in hundredths)

1.70%

0.80%

0.10%

Expected volatility (in hundredths)

58.00%

72.00%

45.00%

66.00%

Average expected term (in years)

'5 years

'1 year

Expected dividend yield (in hundredths)

0.00%

Weighted average fair value of options granted (in dollars per share)

$0.97

$1.53

$1.84

$2.62

Weighted average fair value of purchase option (in dollars per share)

$1.85

[1]

$2.11

[1]

$0.49

$0.72

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Exercise price range, lower range limit (in dollars per share)

$1.23

$2.04

$3.30

$8.79

Exercise price range, upper range limit (in dollars per share)

$1.93

$3.24

$7.27

$18.98

Outstanding options (in shares)

474,000

317,000

147,000

402,000

Weighted average remaining contractual life

'4 years 6 months

'6 years 10 months 24 days

'2 years 8 months 12 days

'2 years 6 months

Weighted average exercise price (in dollars per share)

$1.92

$3.19

$5.49

$9.49

Exercisable options (in shares)

466,000

240,000

147,000

402,000

Weighted average exercise price (in dollars per share)

$1.93

$3.20

$5.49

$9.49

[1]

Years 2013 and 2014 restricted stock units granted include 560 and 412.5 performance-based restricted stock units, respectively.

[2]

Year 2013 restricted stock units forfeited include 384 performance-based units; Year 2013 stock options forfeited include 42 performance-based option shares.

[3]

In the second quarter of 2013, 125 time-based and 83 (125 at maximum performance achievement) performance-based stock options were rescinded with the consent of and without payment to the CEO due to the fact that the original grants with respect to which these options were a part of exceeded the sub-limits of the applicable plan by the number of shares as to which the options were rescinded.

LOSS_PER_SHARE_Details

LOSS PER SHARE (Details)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014		Mar. 30, 2013
LOSS PER SHARE [Abstract]	'		'
Weighted average common shares for basic loss per share (in shares)	84,763		73,158
Effect of dilutive securities: [Abstract]	'		'
Stock options (in shares)	0	[1]	0	[1]
Unvested restricted shares (in shares)	0	[1]	0	[1]
Adjusted weighted average shares for diluted loss per share (in shares)	84,763		73,158
Stock Options [Member]	'		'
Antidilutive Securities Excluded From Computation Of Earning Per Share [Abstract]	'		'
Antidilutive securities excluded from computation of earnings per share (in shares)	1,340		2,437
Unvested Restricted Shares and Units [Member]	'		'
Antidilutive Securities Excluded From Computation Of Earning Per Share [Abstract]	'		'
Antidilutive securities excluded from computation of earnings per share (in shares)	3,646		1,627

[1]	Incremental shares from restricted shares and stock options are computed using the treasury stock method.

ACCUMULATED_OTHER_COMPREHENSIV2

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014		Mar. 30, 2013
Accumulated Other Comprehensive Income Loss [Line Items]	'		'
Beginning Balance	$1,647		$3,252
Other comprehensive income before reclassifications	-37		1,118
Amounts reclassified from accumulated other comprehensive income	-1,160	[1]	-29	[1]
Net current period other comprehensive income	-1,197		1,089
Ending Balance	450		4,341
Net Unrealized Gain (Loss) on Marketable Securities [Member]	'		'
Accumulated Other Comprehensive Income Loss [Line Items]	'		'
Beginning Balance	1,647		3,255
Other comprehensive income before reclassifications	-37		1,118
Amounts reclassified from accumulated other comprehensive income	-1,160	[1]	-29	[1]
Net current period other comprehensive income	-1,197		1,089
Ending Balance	450		4,344
Foreign Currency Translation [Member]	'		'
Accumulated Other Comprehensive Income Loss [Line Items]	'		'
Beginning Balance	0		-3
Other comprehensive income before reclassifications	0		0
Amounts reclassified from accumulated other comprehensive income	0	[1]	0	[1]
Net current period other comprehensive income	0		0
Ending Balance	$0		($3)

[1]	Amounts reclassified are recorded within Other income, net in the Condensed Consolidated Statements of Operations.

LINE_OF_CREDIT_Details

LINE OF CREDIT (Details) (Line Of Credit [Member], USD $)	1 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014
Line Of Credit [Member]	'
Line Of Credit Facility [Line Items]	'
Term of line of credit facility	'3 years
Revolving credit facility, Amount	$11,000
Revolving credit facility, Expiration date	30-Apr-16
Variable rate basis	'LIBOR
Basis spread on variable rate (in hundredths)	3.25%